Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research ...

BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I ...

On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation ...